Cheng Zhao

858 total citations
36 papers, 376 citations indexed

About

Cheng Zhao is a scholar working on Pathology and Forensic Medicine, Rheumatology and Immunology. According to data from OpenAlex, Cheng Zhao has authored 36 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 15 papers in Rheumatology and 11 papers in Immunology. Recurrent topics in Cheng Zhao's work include Systemic Sclerosis and Related Diseases (14 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune Bullous Skin Diseases (5 papers). Cheng Zhao is often cited by papers focused on Systemic Sclerosis and Related Diseases (14 papers), Systemic Lupus Erythematosus Research (11 papers) and Autoimmune Bullous Skin Diseases (5 papers). Cheng Zhao collaborates with scholars based in China, Singapore and United States. Cheng Zhao's co-authors include Ling Lei, Xu Wang, Zhiyi He, Xiao-ning Zhong, Jie Pan, Jing Wen, Zhiyi He, Xiaoning Zhong, Xuejiao Sun and Juan Chen and has published in prestigious journals such as Chemical Engineering Journal, Journal of Materials Chemistry A and Frontiers in Immunology.

In The Last Decade

Cheng Zhao

32 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheng Zhao China 11 121 119 98 74 56 36 376
Koji Adachi Japan 13 34 0.3× 54 0.5× 46 0.5× 39 0.5× 51 0.9× 53 455
Pietro Gangemi Italy 9 57 0.5× 155 1.3× 39 0.4× 69 0.9× 24 0.4× 18 454
A. Schröder Germany 10 32 0.3× 96 0.8× 127 1.3× 27 0.4× 54 1.0× 31 456
Ruojun Wang China 12 53 0.4× 36 0.3× 46 0.5× 159 2.1× 97 1.7× 49 481
Chiara Puricelli Italy 11 46 0.4× 63 0.5× 40 0.4× 21 0.3× 22 0.4× 21 489
Ruiqin Mai China 15 79 0.7× 40 0.3× 45 0.5× 73 1.0× 49 0.9× 28 500
Aslı Bilgiç Temel Türkiye 11 327 2.7× 48 0.4× 30 0.3× 268 3.6× 80 1.4× 42 513
Toomas Talme Sweden 9 35 0.3× 312 2.6× 39 0.4× 50 0.7× 217 3.9× 11 542
Kazunori Tahara Japan 15 43 0.4× 63 0.5× 96 1.0× 20 0.3× 8 0.1× 53 634
Atrin Toussi United States 9 51 0.4× 87 0.7× 13 0.1× 38 0.5× 173 3.1× 23 417

Countries citing papers authored by Cheng Zhao

Since Specialization
Citations

This map shows the geographic impact of Cheng Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Zhao more than expected).

Fields of papers citing papers by Cheng Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Zhao. The network helps show where Cheng Zhao may publish in the future.

Co-authorship network of co-authors of Cheng Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng Zhao. A scholar is included among the top collaborators of Cheng Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng Zhao. Cheng Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhao, Cheng, Shixiang Zhou, Jie Ma, et al.. (2025). Highly conductive PANI/ATMP/AgNO 3 composite hydrogel electrodes for all-hydrogel-state supercapacitors. Journal of Materials Chemistry A. 13(7). 5238–5251. 12 indexed citations
3.
Bai, Wei, Hui Luo, Huaxiang Wu, et al.. (2025). Effectiveness and safety of tacrolimus in systemic lupus erythematosus with various clinical manifestations: a retrospective real-world study. Arthritis Research & Therapy. 27(1). 198–198.
4.
Wang, Ziqian, Jiuliang Zhao, Qian Wang, et al.. (2024). Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI. RMD Open. 10(3). e004425–e004425. 1 indexed citations
5.
Wang, Di, Cheng Zhao, Hua Song, et al.. (2024). The impact of neutrophil count on the results of metagenomic next-generation sequencing in immunocompromised febrile children. Heliyon. 10(12). e32816–e32816. 1 indexed citations
6.
Zheng, Leting, et al.. (2024). Development and validation of a new diagnostic prediction model of ENHO and NOX4 for early diagnosis of systemic sclerosis. Frontiers in Immunology. 15. 1273559–1273559. 2 indexed citations
7.
Pan, Jie, et al.. (2023). The role of iTr35 cells in the inflammatory response and fibrosis progression of systemic sclerosis. Lara D. Veeken. 62(10). 3439–3447. 3 indexed citations
8.
Zhao, Cheng, Hao‐Jie Zhu, Xu Lu, et al.. (2023). β-glucan, a specific immuno-stimulant, produces rapid antidepressant effects by stimulating ERK1/2-dependent synthesis of BDNF in the hippocampus. European Journal of Pharmacology. 961. 176161–176161. 14 indexed citations
9.
Li, Meicheng, Xinwang Duan, Li Q, et al.. (2023). [Clinical characteristics of patients with rheumatic diseases and abnormal liver function].. PubMed. 62(9). 1102–1113.
10.
Jiang, Nan, Qin Li, Hongbin Li, et al.. (2022). Chinese registry of rheumatoid arthritis (CREDIT) V: sex impacts rheumatoid arthritis in Chinese patients. Chinese Medical Journal. 135(18). 2210–2217. 7 indexed citations
11.
Su, Jinmei, Runsheng Wang, Yanhong Wang, et al.. (2022). Clinical characteristics of axial spondyloarthritis patients in China: results from ChinaSpA, the Chinese Spondyloarthritis Registry. Clinical and Experimental Rheumatology. 40(3). 544–550. 5 indexed citations
12.
Li, Wenyu, Cheng Zhou, Yue Wei, et al.. (2022). Circular RNA expression profile of systemic lupus erythematosus and its clinical significance as a potential novel biomarker. Genes & Genomics. 44(11). 1405–1414. 2 indexed citations
13.
Shi, Yue, Yanhong Wang, Ruofan Li, et al.. (2022). Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus. Frontiers in Medicine. 9. 984183–984183. 1 indexed citations
14.
Chen, Juan, et al.. (2021). Clinical features and prognostic factors of systemic sclerosis in Guangxi, China: Retrospective, single‐center study of long‐term survival in 470 patients. International Journal of Rheumatic Diseases. 25(2). 182–191. 6 indexed citations
15.
Zhang, Yidan, Jie Tian, Fan Xiao, et al.. (2021). B cell-activating factor and its targeted therapy in autoimmune diseases. Cytokine & Growth Factor Reviews. 64. 57–70. 26 indexed citations
16.
Huang, Jing‐Long, Wei Hua, Fang He, et al.. (2020). THU0270 ONLINE INTERACTION AND FREQUENT SELF-ASSESSMENTS PROMOTED TREAT-TO-TARGET FOR SLE VIA EMPOWERING PATIENTS: A COHORT STUDY FROM CHINA BY SMART SYSTEM OF DISEASE MANAGEMENT (SSDM). Annals of the Rheumatic Diseases. 79. 361–362. 1 indexed citations
17.
Zhang, Shangzhu, Yanhong Wang, Linyi Peng, et al.. (2020). Comparison of Clinical Features in HLA-B27 Positive and Negative Patients With Axial Spondyloarthritis: Results From a Cohort of 4,131 Patients. Frontiers in Medicine. 7. 609562–609562. 17 indexed citations
18.
Lü, Yi, Cheng Zhao, Ling Lei, et al.. (2019). Effects of thalidomide on Th17, Treg cells and TGF‐β1/Smad3 pathway in a mouse model of systemic sclerosis. International Journal of Rheumatic Diseases. 23(3). 406–419. 9 indexed citations
19.
Chen, Juan, Ling Lei, Jie Pan, & Cheng Zhao. (2019). A meta-analysis of fracture risk and bone mineral density in patients with systemic sclerosis. Clinical Rheumatology. 39(4). 1181–1189. 12 indexed citations
20.
Lei, Ling, Xiaoning Zhong, Zhiyi He, Cheng Zhao, & Xuejiao Sun. (2014). IL‐21 induction of CD4+ T cell differentiation into Th17 cells contributes to bleomycin‐induced fibrosis in mice. Cell Biology International. 39(4). 388–399. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Koji Adachi Breakdown of academic impact, for papers by Pietro Gangemi Breakdown of academic impact, for papers by A. Schröder Breakdown of academic impact, for papers by Ruojun Wang Breakdown of academic impact, for papers by Chiara Puricelli Breakdown of academic impact, for papers by Ruiqin Mai Breakdown of academic impact, for papers by Aslı Bilgiç Temel Breakdown of academic impact, for papers by Toomas Talme Breakdown of academic impact, for papers by Kazunori Tahara Breakdown of academic impact, for papers by Atrin Toussi
Rankless by CCL
2026